Naphtali Milliken

Statistics

Publications

Citations

251

H-Index

Active since

2007

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

Naphtali Milliken is an author at Research Triangle Park Foundation specializing in nicotinamide adenine dinucleotide metabolism, pharmacology, and cd38-mediated nad+ metabolism.

Publications per year

2007–2015

Publications

Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors

Curt D. Haffner, J. David Becherer, Eric E. Boros et al. · Journal of Medicinal Chemistry · 2015 · 136 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

The Effect of PPAR<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>α</mml:mi></mml:math>, PPAR<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>δ</mml:mi></mml:math>, PPAR<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>γ</mml:mi></mml:math>, and PPARpan Agonists on Body Weight, Body Mass, and Serum Lipid Profiles in Diet-Induced Obese AKR/J Mice

W. Wallace Harrington, Christy S. Britt, Joan G. Wilson et al. · PPAR Research · 2007 · 71 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Genetic Ablation of CD38 Protects against Western Diet-Induced Exercise Intolerance and Metabolic Inflexibility

Shian-Huey Chiang, W. Wallace Harrington, Guizhen Luo et al. · PLoS ONE · 2015 · 44 citations · Full text

Life Sciences, Biochemistry, Physiology +17

1–3 of 3